In addition, the CB2 agonist induced cytotoxicity and apoptosis in human colorectal cancer cells (HT-29) [14], and the selective CB2 agonist JWH-133 induced a considerable regression of malignant tumors generated by the inoculation of C6 glioma cells [15]. The gene discussed is CNR2; the disease is central nervous system cancer.